Peter F. Lebowitz
CIK: 0002121402
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBOT
BridgeBio Oncology Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Lebowitz Peter F
Lebowitz Peter F (SEC CIK 0002121402) files insider reports with the SEC as Director of BridgeBio Oncology Therapeutics, Inc. (BBOT).
Signal8 holds 3 ownership filings by Lebowitz Peter F (1 Form 3, 2 Form 4), filed between Mar 26, 2026 and Jun 18, 2026. Those filings report 2 transactions, from Mar 24, 2026 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lebowitz Peter F's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Lebowitz Peter F
Other insiders filing for BridgeBio Oncology Therapeutics, Inc. (BBOT)
- Cobo Marc, Principal Accounting Officer
- Elmelech Idan, COO & Principal Financial Ofcr
- Beltran Pedro, President and CEO
- Ben Yong, Chief Med & Dev Officer
- Chen Bihua, Director
- Tipirneni Praveen P., Director